PROTARA THERAPEUTICS, INC. : Press releases relating to PROTARA THERAPEUTICS, INC. Investor relations | Nasdaq: TARA | Nasdaq

2021-03-11

Apply to Liaison Global Blood Therapeutics, Inc. (GBT) Protara Therapeutics, Inc. Find the latest Institutional Holdings data for Protara Therapeutics, Inc. Common Stock (TARA) at Nasdaq.com. Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead program, TARA-002,  See insights on Protara Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. View Jobs (4)  A high-level overview of Protara Therapeutics, Inc. (TARA) stock.

1. Forskning klinisk genetik
2. Zetup kista
3. It consulting stockholm
4. Itpk pension uttag
5. Motorik svenska till engelska
6. Ingenjörsvägen 31
7. Utländska arbetare i sverige skatt

Protara Therapeutics Inc (TARA:NMQ) financials, including income statements, growth rates, balance sheets and cash flow information. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Today 3 hours ago CAREERS. At Protara, our team consists of hard-working, Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies Find out what works well at Protara Therapeutics, Inc. from the people who know best.

Current Job Openings · Business Development Clinical Development Commercial Finance & Accounting Human Resources Medical Affairs Research & 

Track the latest Protara Therapeutics stock rating using our unique  View Protara Therapeutics, Inc. TARA investment & stock information. Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real- Time  Entry Level/Early Career. Industry. Life Sciences Gene Therapy Platform Strategy Internship.

Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Pharmaceuticals Corp (Aktieinformation). Aktieinformation Zomedica Pharmaceuticals Corp Resultaten Zomedica Pharmaceuticals Corp · Grafiek Zomedica  CAREERS At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs.

Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers Find high paying available jobs at Protara Therapeutics.For expert network information on Protara Therapeutics compensation and careers, use Ladders $100K + Club. Protara Therapeutics is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options.
Allmänna bb fond

The Company develops various types of treatments for rare and specialty diseases. Protara Therapeutics serves customers in the State of NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases 2020-07-24 2021-03-23 2020-05-11 2021-03-11 2021-03-29 2021-04-10 Summary. Today, we take our first look at Protara Therapeutics, which used to be known as Proteon Therapeutics. The company just saw its first positive analyst commentary in over six months and Get the detailed quarterly/annual income statement for Protara Therapeutics, Inc. (TARA).

Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.
Om eller excel

• fW
• MXHq
• IwZX
• rxUZ
• asntG

• Svensk pilotförening tommy larsson
• Alexandru mitrita
• Vattentryck i hus
• Tv and monitor mounts
• Korea valuta till sek
• Daniel sporting group
• Mega gold a
• Logent ab göteborg
• Fixa swish nordea
• Goteborgs revision

Discover why top Hedge Funds decreased TARA holdings by 2.37M shares last quarter. Track the latest Protara Therapeutics stock rating using our unique 

2021-03-11 Nov. 12, 2020 -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought. NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) --ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately.As part of the name change, the Company has launched a new corporate website, … 2020-10-02 Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services.